Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001674236-26-000022
Filing Date
2026-09-01
Accepted
2026-09-01 18:18:41
Documents
1
Period of Report
2026-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1788301118.html 4  
1 FORM 4 wk-form4_1788301118.xml 4 3715
  Complete submission text file 0001674236-26-000022.txt   5393
Mailing Address 104 CARNEGIE CENTER DRIVE SUITE 300 PRINCETON NJ 08540
Business Address 104 CARNEGIE CENTER DRIVE SUITE 300 PRINCETON NJ 08540 6097591810
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANI PHARMACEUTICALS, INC. 104 CARNEGIE CENTER, SUITE 300 PRINCETON NJ 08540
Business Address
CAREY STEPHEN P. (Reporting) CIK: 0001674236 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 261352090